Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Echosens
- Study ID
- NCT07222813
- Status
- Recruiting
Conditions
- Heart Failure
- Heart Failure - NYHA II - IV
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- FibroScan — DEVICEAt Day 0: 1 FibroScan examination to collect Liver Stiffness Measurement (LSM)
- Right-sided Heart Catheterization — PROCEDUREat Day 0: Right-sided Heart Catheterization (RHC) to measure Central Venous Pressure (CVP)
- Transthoracic echocardiography — PROCEDUREat Day 0 assessment of cardiac function
- Blood Sample Analysis — BIOLOGICALAt Day0: To assess baseline organ function that may impact participant safety, and blood samples for clinical laboratory tests
Study Details
This is a pivotal, global, prospective, cross-sectional, multicentric clinical investigation designed to explore a non-invasive, reliable alternative to invasive, catheter-based hemodynamic assessments, which are associated with procedural risks and limited applicability in certain participant populations.
Key Dates
- First listed
- Oct 30, 2025
- Start date
- Apr 23, 2026
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2027
- Completion
- Jan 15, 2028
Study Design
- Enrollment
- 149 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Full CohortThis population will be defined by patients fulfilling all inclusion and exclusion criteria.
Primary Outcome Measure
Proportion of individuals with elevated CVP (>10 mm Hg) who are correctly identified by LSM (cutoff of 13.3 kPa) [Sensitivity] [ Time Frame: at Day 0 ]
Central Contacts
- CAROLE MEILLEROUX, PharmD+33622649277
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Keck Medicine of USC-Norris Healthcare Center - Transplant Clinic | Los Angeles | California | 90033 | Michael Fong, MD |
| University of Minnesota | Minneota | Minnesota | 55455 | |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | |
| University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location | Dallas | Texas | 75390 |
Find similar trials in Los Angeles, CA
By condition
By specialty
By research site
Keck Medicine of USC-Norris Healthcare Center - Transplant Clinic· Los Angeles, CAUniversity of Minnesota· Minneota, MNMedical University of South Carolina· Charleston, SCUniversity of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location· Dallas, TX
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Dallas, Texas
- Get With The Guidelines-Heart Failure RegistryRecruiting · American Heart Association · Dallas, Texas
- His Bundle Pacing in Bradycardia and Heart FailureRecruiting · Yong-Mei Cha · Rochester, Minnesota